Management of Acute Febrile Illness
The management of acute febrile illness should follow a structured approach focusing on early identification of the cause, appropriate antimicrobial therapy when indicated, and supportive care to reduce morbidity and mortality.
Initial Assessment and Diagnosis
Vital Signs Monitoring
- Monitor temperature, respiratory rate, pulse, blood pressure, mental status, oxygen saturation at least twice daily 1
- Use Early Warning Score system for efficient monitoring 1
- Look for signs of clinical instability:
- Temperature >37.8°C
- Heart rate >100/min
- Respiratory rate >24/min
- Systolic blood pressure <90 mmHg
- Oxygen saturation <90%
- Inability to maintain oral intake
- Abnormal mental status 1
Diagnostic Testing
- For respiratory symptoms: Chest X-ray 2
- For severe illness: Blood cultures 2
- For productive cough: Sputum Gram stain and culture 2
- Calculate CURB-65 score if pneumonia is suspected 2
Treatment Approach
Antiviral Therapy
Initiate antiviral therapy (neuraminidase inhibitors) if:
- Acute influenza-like illness
- Fever >38°C
- Symptoms present for ≤2 days 2
Recommended regimen:
Special considerations:
Antibiotic Therapy
For Influenza Without Pneumonia
- Antibiotics not routinely required for previously well adults with acute bronchitis 1
- Consider antibiotics for:
- Worsening symptoms (recrudescent fever or increasing dyspnoea)
- High-risk patients with lower respiratory features 1
For Non-Severe Influenza-Related Pneumonia
- Oral therapy preferred: co-amoxiclav or tetracycline 1
- When oral therapy contraindicated: IV co-amoxiclav, or cefuroxime/cefotaxime 1
- Alternative for penicillin-intolerant patients: macrolide (clarithromycin/erythromycin) or respiratory fluoroquinolone 1
- Administer antibiotics within 4 hours of admission 1
For Severe Influenza-Related Pneumonia
- Immediate parenteral antibiotics after diagnosis 1
- Preferred regimen: IV combination of broad-spectrum beta-lactamase stable antibiotic (co-amoxiclav or cephalosporin) plus macrolide 1
Supportive Care
- Acetaminophen: 650-1000 mg every 4-6 hours (maximum 4000 mg/day) for fever and pain 2
- Dextromethorphan: 10-30 mg every 4-8 hours for non-productive cough 2
- Guaifenesin: 200-400 mg every 4 hours for productive cough 2
- Pseudoephedrine: 60 mg every 4-6 hours for nasal congestion (use with caution in patients with hypertension) 2
- Ensure adequate fluid intake and rest 2
- Provide nutritional support in severe or prolonged illness 1
- Assess for cardiac complications and volume depletion 1
Special Considerations
High-Risk Patients
- More vigilant monitoring for:
- Elderly (≥65 years)
- Children <2 years
- Patients with chronic medical conditions
- Immunocompromised individuals
- Pregnant women 2
Discharge Criteria
- Patients should be stable for at least 24 hours before discharge
- No more than one of the following unstable clinical factors:
- Temperature >37.8°C
- Heart rate >100/min
- Respiratory rate >24/min
- Systolic blood pressure <90 mmHg
- Oxygen saturation <90% 1
Follow-up
- Consider follow-up for patients who:
- Suffered significant complications
- Had significant worsening of underlying disease 1
- Provide information about illness, medications, and follow-up arrangements at discharge 1
Common Pitfalls to Avoid
- Overtreatment with antimalarial drugs despite negative test results 4
- Overuse of empiric antibiotics for viral etiologies 4
- Failure to consider non-influenza viral causes of febrile illness 4
- Inadequate infection control measures leading to healthcare worker exposure 5
- Delayed antibiotic administration in severe cases (should be within 4 hours) 1